Genentech, Inc.
About Genentech, Inc.
1691 articles about Genentech, Inc.
-
FDA Approves Dako A/S's HercepTest(TM) and HER2 FISH pharmDx(TM) Kit as Companion Diagnostics for Genentech's New Cancer Drug Perjeta(TM)
6/12/2012
-
Genentech Eagerly Awaits FDA Word on 2nd Breast Cancer Drug
6/11/2012
-
Ensemble Therapeutics Corporation and Genentech Initiate Collaboration to Discover Macrocyclic Drug Candidates
5/29/2012
-
Roche's Genentech to Take Part in First-ever Alzheimer's Prevention Trial
5/21/2012
-
Genentech Will Report New Data on Important Progress for People With Advanced Cancers at American Society of Clinical Oncology 2012
5/16/2012
-
Array BioPharma, Inc. and Genentech's Strategic Alliance Voted Breakthrough Alliance of 2012
5/15/2012
-
Genentech Says SUMMACTA Study Meets Primary Endpoint
5/3/2012
-
Dako A/S, Genentech Ink Pact on the FDA Regulatory Submissions of Dako's HercepTest(TM) and HER2 FISH pharmDx(TM) as Companion Diagnostics for Trastuzumab Emtansine (T-DM1)
5/1/2012
-
Genentech and Pfizer Inc. Share CDx Success Insights at the 4th Molecular Diagnostics for Cancer Drug Development in Boston
4/13/2012
-
New Genentech Breast Cancer Drug Shows Late Stage Trial Success
4/2/2012
-
Genmab A/S Says GlaxoSmithKline Settles Patent Case With Genentech
3/27/2012
-
Genentech's ACTEMRA® Shows Superiority in Rheumatoid Arthritis Signs and Symptoms Versus Adalimumab
3/5/2012
-
FDA Grants Genentech’s Pertuzumab Priority Review for Previously Untreated HER2-Positive Metastatic Breast Cancer
2/7/2012
-
Roche Settles Claims Over Genentech's Raptiva Psoriasis Drug, Lawyer Says
1/24/2012
-
Genentech Pours $95 Million into Constellation Pharmaceuticals Epigenetic Drug Platform, Deal Includes M&A Terms
1/17/2012
-
Genentech Announces First Milestone Payment to Device-Maker ForSight Labs, LLC VISION4, Inc. in Development of Sustained Delivery Lucentis
1/17/2012
-
Genentech Announces First Milestone Payment to Device-Maker ForSight Labs, LLC VISION4, Inc. in Development of Sustained Delivery Lucentis
1/13/2012
-
Vernalis PLC Signs Drug-Discovery Deal With Genentech
1/4/2012
-
Regeneron Pharmaceuticals, Inc. Announces Settlement of Patent Litigation with Genentech for U.S. Ophthalmic Sales of EYLEA(TM) (aflibercept) Injection
1/3/2012
-
Genentech Initiates First-in-Human Study with NovImmune SA's Anti-IL17 Antibody
12/13/2011